Admission, discharge, and transfer system

Patient Admissions, Discharges and Transfer Notifications Enable Proactive Healthcare Delivery to Providers

Retrieved on: 
Tuesday, November 29, 2022
Transfer, Morehouse School of Medicine, ADT, Family medicine, HL7, HIE, Hospital, Health, MBA, Patient, Admission, discharge, and transfer system, Customer integrated system, National Center for Health Statistics, Health information exchange, MD, Hughes, Medical device, Medicine

ATLANTA, Nov. 29, 2022 /PRNewswire/ -- Morehouse School of Medicine and the HI-BRIDGE Health Information Exchange (HIE) have announced the latest enhancement to their platform; ADT (Admissions Discharge Transfer) Alerts.

Key Points: 
  • The ADT event notification service will allow clinicians, providers, and payors to receive real-time alerts on patient-related events throughout the Georgia Health Information Network (GaHIN).
  • "Event notifications play a critical role in coordinating and providing quality patient care.
  • The simplified exchange of comprehensive, real-time patient health information supports care coordination and optimal health outcomes by eliminating disparities and improving access to health information.
  • HI-BRIDGE HIE continuously seeks ways to improve the quality of healthcare information delivered to its providers.

New Report Uses the Industry’s Most Comprehensive Dataset From WellSky® to Reveal Lasting Changes in Post-Acute Care

Retrieved on: 
Wednesday, August 31, 2022
Software, Practice Management, Telemedicine, Virtual Medicine, Managed Care, Health, Data Management, Health Technology, Technology, Transfer, Software, Workforce, Babylon (Skindred album), Medicare (United States), Caregiver, Obesity, COVID-19, Rehabilitation, Blood, SNF, Admission, discharge, and transfer system, General number field sieve, Admission, Hospital, Organization, ADT, Movement, Hypertension, Diabetes, Industry, Health, Growth, Government, Patient, Medicine, Pharmaceutical industry

This has caused some inpatient procedures to become outpatient procedures, a trend that may never revert to post-pandemic levels.

Key Points: 
  • This has caused some inpatient procedures to become outpatient procedures, a trend that may never revert to post-pandemic levels.
  • Post-acute care is an integral component of the care continuum and has the power to transform care delivery as we know it today, said WellSky CEO Bill Miller.
  • Effective post-acute care is proven to reduce expensive rehospitalizations, improve health outcomes, and lower the overall cost of care.
  • WellSky is one of Americas largest and most innovative healthcare technology companies leading the movement for intelligent, coordinated care.

Genexine Announces Dosing of First Patient in Phase 2 clinical trial with Triple Combination Therapy in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)

Retrieved on: 
Wednesday, August 17, 2022
Oncology, Health, Hospitals, Clinical Trials, Pharmaceutical, Biotechnology, Transfer, Data analysis, International Classification of Functioning, Disability and Health, Mortality, NIH, Oropharyngeal cancer, CEO, Population, Standard of care, Cervical cancer, DART, Cancer, Leadership, KOSDAQ, National Institute, PD-1, Incidence, B cell, Admission, discharge, and transfer system, Department, Patient, DNA, Professor, Judgement, Therapy, CKD, Tumor microenvironment, Nivolumab, Safety, National Institutes of Health, Head, Goal, Glioblastoma, Triple-negative breast cancer, HPV, Disease, Pharmaceutical industry, Vaccine, HNSCC

The trial will evaluate the safety and efficacy in 21 patients with HPV-16 or 18-positive recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).

Key Points: 
  • The trial will evaluate the safety and efficacy in 21 patients with HPV-16 or 18-positive recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
  • Endpoints assessed during the study include those related to safety and efficacy, including the overall rate of response.
  • The unmet medical need in HNSCC patients is substantial, so this landmark study will be an important milestone for these patients.
  • Recurrent/metastatic head and neck squamous cell carcinoma is considered an incurable disease with a very poor prognosis and limited treatment options.

Genexine reports encouraging top-line results of the Phase 1b/2 clinical trial with GX-I7 (efineptakin alfa) in refractory or recurrent (R/R) metastatic Triple Negative Breast Cancer

Retrieved on: 
Tuesday, June 7, 2022
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Transfer, Oncology, NLR Air Transport Safety Institute, Lymphocytopenia, Immunotherapy, Goal, Company, TNBC, Society, American Society of Clinical Oncology, Safety, ORR, Admission, discharge, and transfer system, Severance Hospital, CEO, ASCO, KOSDAQ, Biopsy, Therapy, Cervical cancer, Pembrolizumab, Patient, DART, Review, DNA, Immune system, Judgement, Data analysis, Homeostasis, CPS, Particle-size distribution, CKD, Cancer, PD-L1, Pharmaceutical industry

Top-line data showed that GX-17 in combination with pembrolizumab was safe and well tolerated in the overall phase 1b/2 trial.

Key Points: 
  • Top-line data showed that GX-17 in combination with pembrolizumab was safe and well tolerated in the overall phase 1b/2 trial.
  • Observed ORRs with GX-17 in combination pembrolizumab were 15.7% (8/51) for phase 1b and 21.2% (7/33) for phase 2.
  • Of the 25 patients who had an evaluable PD-L1 from a biopsy sample, 40.0% (10/25) were PD-L1 positive (CPS10).
  • GX-I7 represents a new class of potential therapy for cancer patients and could become the first therapy to manage lymphopenia in cancer patients.

Blue by ADT Launches a Comprehensive DIY Smart Home Security System

Retrieved on: 
Tuesday, September 1, 2020
Articles, Internet of things, Crime prevention, Home, Home security, Security, Ring, Admission, discharge, and transfer system, ADT, Boca Raton, Florida, Smart doorbell, Home automation

BOCA RATON, Fla., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Today, Blue by ADT , the recently introduced DIY smart home security brand from ADT (NYSE: ADT) , is expanding its product lineup to offer fully customizable DIY smart home security solutions.

Key Points: 
  • BOCA RATON, Fla., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Today, Blue by ADT , the recently introduced DIY smart home security brand from ADT (NYSE: ADT) , is expanding its product lineup to offer fully customizable DIY smart home security solutions.
  • Blue by ADT is a flexible, expandable DIY system that allows customers to design a smart home security system customizable to their individual needs while simultaneously offering the peace of mind that comes with ADTs professional monitoring capabilities.
  • The Blue by ADT DIY comprehensive smart home security solution includes a smart home hub with integrated keypad, indoor, outdoor and doorbell cameras, door and window sensors, motion sensor, and a combination flood and temperature sensor.
  • Included with every system is the free Blue by ADT app, where customers have mobile access and control of their Blue by ADT system with unique user arm/disarm codes, live streaming, video recording, system arming/disarming, and 24/7 event alerts.

Chief Collision Technology's New Mosaic ADT Improves Speed and Accuracy of ADAS Recalibration Repairs

Retrieved on: 
Tuesday, November 19, 2019
Articles, Automotive accessories, Automotive aftermarket, Automotive industry, Electric vehicle conversion, Vehicle modification, Mosaic, Technology, Plumb bob, Motor vehicles, Admission, discharge, and transfer system, Aftermarket

Unlike other aftermarket systems that rely on centering, squaring and positioning targets by manually using tape measures, plumb bobs and chalk lines, Mosaic ADT does it automatically.

Key Points: 
  • Unlike other aftermarket systems that rely on centering, squaring and positioning targets by manually using tape measures, plumb bobs and chalk lines, Mosaic ADT does it automatically.
  • Mosaic ADT offers a cost-effective aftermarket solution using factory developed calibration technology to place vehicles on the road safely."
  • A technician drives the vehicle in front of the Mosaic ADT system and plugs into the ODBII port of the vehicle.
  • Chief is a collision repair technology company that gives modern body shops the tools, technology and training they need to perform accurate repairs.